Thompson Elizabeth H.Z.'s Form 4 filing
Horizon Therapeutics Public Ltd Co (HZNP) · filed Jul 11, 2022
- Accession no.
- 0001209191-22-041840
- Filed
- Jul 11, 2022
- Trade date
- Jul 7, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $6.97K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thompson Elizabeth H.Z.CIK 0001861477 | Officer (EVP, Research & Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2022 | Ordinary Shares | SSaleDisposed | −82 | $85.01 | −$6,970.82 | 12,976 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.